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INTRODUCTION
Extensive study of the pathophysiology of NIDDM
has enabled the identification of two defects, insulin
resistance and impaired β-cell function. These two
fundamental defects, included in the pathogenesis
of NIDDM, are caused by a combination of genetic
and environmental factors (1). However, controver-
sy persists concerning which defect can be detected
earliest in the course of NIDDM. In prediabetic
obese individuals, such as Pima Indians, β-cells can
compensate for insulin resistance by sufficiently
increasing insulin secretion and enhancing β-cell
sensitivity to glucose, but when the β-cell response
is inadequate, glucose intolerance becomes apparent
(2). According to this view, primary insulin resist-
ance occurs first and results in hyperinsulinemia
with several metabolic consequences and ultimately
endocrine decompensation (3). No investigative study
to gather direct evidence of the primary defect in
the endocrine pancreas can be performed on humans,
such as Pime Indians who later develop NIDDM.
However, animal models do provide an opportunity
to study this problem.
Caloric restriction and/or exercise training are
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known to be effective in the therapy of diabetes
mellitus for stabilizing glucose homeostasis and
improving diabetic control. It is uncertain whether
these therapies are effective in preventing diabetes,
although several indirect lines of evidence support
the concept that they have a protective effect. There
is no direct evidence for their preventive effect on
the development of NIDDM, since implementing
such preventive measures is difficult in humans.
However, this possibility can be examined in animal
models.
In 1983, a spontaneously diabetic rat with mild
obesity was discovered in an out-breeding colony of
Long-Evans rats at the Tokushima Research Institute
of Otsuka Pharmaceutical Company (Tokushima,
Japan). The rat was subsequently maintained and
after 20 generations of selective breeding, a diabetic
strain, named the Otsuka Long-Evans Tokushima
Fatty (OLETF) rat, was established in 1990 (4).
The cumulative incidences of diabetes in male rats
are 67%, 78%, and 81.2% at 4, 6 and 10 months of
age, respectively. On the other hand, the cumulative
incidences in female rats, which do not become obese
under ordinary feeding, are very low at all ages. A
diabetogenic gene (ODB-1) has been reported to
be located on the X-chromosome in OLETF rats
(5). A control strain, the Long-Evans Tokushima
Otsuka (LETO) rat, which originated from the same
Long-Evans stock, shows normal responses to an
oral glucose tolerance test throughout life.
In this paper, we will review two matters as fol-
lows : 1) what is the real pathoetiology of impaired
β-cell function in NIDDM, and 2) whether inter-
ventions such as caloric restriction and exercise
training have preventive effects on the onset and
development of NIDDM
1. What is a pathoetiologic event of β-cell
dysfunction in NIDDM?
Although various abnormalities in the pancreas
of the OLETF rats have been described, their pres-
ence may not be sufficient to explain the pancreas,
inability to meet the abnormal metabolic demands
for insulin to control diabetes when diabetogenic
factors are sustained. It would, therefore, be inter-
esting to know if the poor capacity for proliferation
of pancreatic β-cells contributes critically to the
inability to compensate for an increased insulin de-
mand. To test this hypothesis, we used a partially
pancreatectomized rat as a model to determine
whether there is a difference in the compensatory
capacity of pancreatic β-cell proliferation between
OLETF and their diabetes-resistant counterparts,
LETO rats, and whether this difference, if any,
contributes to impairment of the carbohydrate me-
tabolism. For this purpose, the animals at 6 weeks
of age were allocated at random to two groups :
70% Px and sham Px. Each group was divided into
four subgroups according to the date of sacrifice
after surgery : 3-day, 7-day, 28-day (treated with
phlorizin, nicotinamide, or saline), and 91-day. The
compensatory capacity of the pancreatic remnant
was determined by comparing the changes in blood
glucose levels and compensatory proliferation of
the pancreatic remnant after surgery.
1) Quantification of extent of pancreatectomy (Px)
The operation for a 70% Px was performed as
follows. After an overnight starvation, the animals
were anesthetized with ether and given additional
ether, if required, during surgery. All pancreatic
tissue was removed by gentle abrasion with cotton
applicators, except for the anatomically well-definded
remnant bordered by the branch of the hepatic
portal vein and the first portion of the duodenal loop.
The sham operation was performed by disengaging
the pancreas from the mesentery and gently rubbing
it between the fingers. All operations were per-
formed by one person, whose surgical technique
was well controlled, and as a result, the samples of
the removed segments from each group gave an
expected coefficient variation of 10%. At that time
(6 weeks of age), the remnant equivalent of the
pancreas (the portion of the pancreas with the same
anatomical boundaries as the remnant left in the
70% Px rats) was 30.4±1.0% (n=11) of the total
pancreatic weight with 27.8±3.7% (n=6) of the total
β-cell mass and 35.6±10.8% (n=5) of the total
insulin content in the OLETF rats. For the LETO
rats, corresponding values were 30.4±1.3% (n=11),
29.4±3.3% (n=6) and 36.0±2.5% (n=5) of the values
for the whole pancreas. No significant difference
was noted for any other morphologic characteris-
tics between OLETF and LETO rats.
2) Hyperglycemia
In the OLETF rats, a 70% Px resulted in signifi-
cant non-fasting hyperglycemia. The blood glucose
level began to increase to 9.4±0.9 mmol/l on day
3 after surgery (Fig.1), and remained above 16.7
mmol/l from the sixth day. No sustained hyper-
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glycemia was noted in the control LETO rats after
surgery. It has been reported that no less than 90%
Px would induce hyperglycemia in the normal rodents,
except for rats with postprandial hyperglycemia
afterm 50% Px and administration of dexamethasone
(6), or with minimal chronic hyperglycemia after
60% Px plus 10% sucrose in the drinking water (7).
The latter findings may have been due to insufficient
compensatory proliferation of residual β-cells to
increased insulin demand caused by administration
of dexamethasone and 10% sucrose. OLETF rats
exhibit insulin resistance at around 12 weeks of
age (8), but not at 6 weeks of age or younger, at
which age they were used in this study. It has been
reported that following a 90% Px in rats, the β-cell
mass in the remaining tissue is enhanced 3-to 4-fold
within a few weeks, suggesting that β-cells, even
in adults, have a far greater capacity to respond to
glucose stimulation with compensatory
growth by enhanced replication and hyper-
trophy of individual cell than previously
realized (9). Furthermore, hyperglycemia
accelerates β-cell mass growth by increas-
ing the number of β-cells undergoing
mitosis (10, 11). Therefore, the sustained
hyperglycemia observed in the Px OLETF
rats very early after surgery would be due
to an insufficient adaptive increase in pro-
liferation of β-cells in response to hyper-
glycemia. To clarify this, we analyzed the
pancreatic β-cell proliferative capacity.
3) Defective proliferation in pancreatic
β-cells
The reduction in β-cell mass is a critical
pathological feature of pancreatic islets in
NIDDM. Animal experiments, however,
indicate that genetic background is of
considerable importance in determining
the proliferative response of β-cells to
diabetogenic factors leading to a lasting
increase in demand for insulin (12, 13).
Our findings showed that at each time
point (3 days, 7 days, 28 days or 91 days),
the remnant equivalents of the sham ani-
mals in both OLETF and LETO rats were
around 30% of the values for the whole
pancreatic weight, suggesting that the rel-
ative growth of the remnant equivalent
was similar to that of the remainder of the
pancreas in the sham rats. It was noted
that the remnant tissue weight, as a per-
centage of the whole pancreatic weight, on day 3
after surgery showed a marked increase in both
Px OLETF and LETO rats. The remnant on day 3
after surgery was somewhat edematous (38.3±1.2%
of whole pancreatic weight in the OLETF and 41.4
±1.9% % of whole pancreatic weight in the LETO
rats), which may have resulted in a slight over-
estimation of the tissue weight. Thereafter further
increase in growth was detected in the Px LETO
rats (36.3±1.5%, 41.0±1.3% and 45.0±3.4% of
whole pancreatic weight on days 7, 28, and 91,
respectively), while no such growth was detected in
the Px OLETF rats ; around 30% of whole pancreatic
weight, similar to the values for the sham rats.
As shown in Fig.2-A with in vivo labeling using
5-bromo-2’-deoxyuridine (BrdU), at a dose of 100
mg/kg BW, proliferation of β-cells from the pancre-
atic remnant was seen during the first 7 days after
Fig.1. Effects of 70% pancreatectomy on non-fasting blood glucose (A) and
body weight (B) of Px OLETF (●), sham OLETF (○), Px LETO (■), and
sham LETO (□) rats during the period of observation. Values shown are for
all surviving rats in each group, the number of which decreased with time as
rats were killed from each subgroup at 3, 7, 28, and 91 days after 70%
pancreatectomy. **P<0.01 vs. all other groups.
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surgery. The mean labeling index (Li) of β-cells in
the sham of both OLETF and LETO rats was higher
than that thereafter, because the pancreas was still
growing rapidly at that age, but did not subsequently
exceed 0.3%/24 hr. However, the mean Li of β-cells
in the Px OLETF rats was higher than that in the
sham rats on day 3. At 7 days, the mean Li of
β-cells was significantly lower in the Px OLETF
rats than in the Px LETO rats. On days 28 and 91,
the mean Li of β-cells not only in the Px OLETF
but also in the Px LETO rats was maintained at a
low level similar to that in the sham rats (less than
0.1%/24h). The BrdU-Li of β-cells we obtained
suggests that the period crucial for expansion of
the β-cell population may be limited to the first 7
days after surgery, which may thus be a critical
compensatory period and mark the compensatory
function of the latter remnant pancreas.
We used Weibel’s point-counting morphometrics
(14) to quantitate the absolute β-cell mass, and then
calculated the percentage of β-cell mass in the
pancreatic remnant to total β-cell mass in whole
pancreas from the sham rats. As shown in Fig.2-B,
the β-cell mass in the pancreatic remnant of the Px
OLETF rats was significantly less than 30% of the
total β-cell mass, except on day 3 after surgery, but
in the Px LETO, the β-cell mass was significantly
higher than the expected value of 30% and reached
45% of the total β-cell mass at 91 days after surgery.
Compared with the Px LETO rats, the β-cell mass
at each time point, as a percentage of the whole
pancreas, showed a progressive decrease in the
Px OLETF rats. As a parallel finding (Fig.2-C), the
insulin content in the remnant from the Px OLETF
rats was significantly less than 30% of the total insulin
content, except on day 3 after surgery, but in the
Px LETO rats, the increased percentage of insulin
content was matched with an increase in β-cell mass,
significantly higher than the expected value of 30%,
and reached 53.1±20.7% of total insulin content at
91 days after surgery.
The elevated labeling of β-cells synthesizing DNA
in the Px LETO rats above that in their sham rats
thus provides evidence of an increase in β-cell number
or greater β-cell proliferation during the period of
observation (15), while decreases in β-cell mass and
insulin content in the Px OLETF rats may be a
reflection of the smaller number of β-cells, and β-cell
degranulation and fibrosis within some islets, which
is known to occur with the defect of β-cell prolif-
eration and sustained hyperglycemia (16).
4) Defectiveβ-cell proliferation unaffected by res-
toration of normoglycemia
Taking account of the hyperglycemic stimulus and
a possible effect of glucose toxicity on proliferative
activity of β-cells, the animals were injected with
phlorizin, 400 mg/kg.body wt. per day, divided into
three equal doses at 8 h intervals to ensure con-
tinuous, day-long inhibition of renal tubular glucose
reabsorption. We used phlorizin not only to elimi-
nate the hyperglycemic stimulus to proliferation
of β-cells, but also to avoid any impaired effect of
hyperglycemia on β-cell function (17). As expected,
the hyperglycemia was normalized with phlorizin,
but this insufficient compensatory capacity for β-cell
growth was not ameliorated in the Px OLETF rats
at 28 days after surgery, suggesting that the abnor-
mality of the proliferative capacity in OLETF rats was
unrelated to both the stimulative and toxic effects
Fig.2. Labeling index (A) with 5-bromo-2’-deoxyuridine, β-cell
mass (B) and insulin contents in pancreatic remnant of Px
OLETF (■) and Px LETO (□) rats at 3, 7, 28 and 91 days after
surgery. *P<0.05, **P<0.01
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of hyperglycemia. It can therefore be concluded
that the poor capacity for proliferation of β-cells may
be genetically determined.
5) Amelioration of hyperglycemia with increasing
β-cell proliferation induced by nicotinamide
To confirm the sustained hyperglycemia as being
due to an uncompensated increase in the β-cell mass
after surgery, nicotinamide, a potent inhibitor of
islet β-cell poly (ADP-ribose) synthase (18-20), at a
dose of 350 mg/kg. BW, was given on the third day
after surgery, at which time hyperglycemia first
became evident in the Px OLETF rats, and was
continued until 28 days after surgery. Non-fasting
blood glucose levels in the Px OLETF rats were
significantly reduced by the administration of
nicotinamide. In the Px OLETF rats, non-fasting
blood glucose values decreased gradually, and
remained at levels that were significantly higher than
in the sham rats, but significantly lower than in the
saline-treated Px rats, and approached the sham levels
at 28 days after surgery. In the nicotinamide-treated
Px rats of both strains, it was clear that a consider-
able increase in the β-cell mass in the Px remnants
had occurred (2.8-fold increase in the Px OLETF
rats and 1.6-fold increase in the Px LETO rats com-
pared with the saline-treated rats). The findings of
the present study provide further support for the
presence of a relationship between sustained hyper-
glycemia and insufficient proliferation of β-cells in
the Px OLETF rats, since the augmented proliferate
capacity by administration of nicotinamide (350 mg/
kg. BW.) manifested as amelioration of the hyper-
glycemia with a significant decrease in non-fasting
blood glucose and increased β-cell mass in the
remnant pancreas. The results we obtained with
nicotinamide suggest that it specifically stimulates
β-cell proliferation in this model rat, because a 3%
increase in the remnant tissue weight in both
OLETF and LETO rats was accompanied by a far
greater increase in the β-cell mass (2.8-fold increase
in the Px OLETF and 1.6-fold increase in the Px
LETO), as compared with that in the saline-treated
counterparts, and the crucial period for expansion
of β-cells was consistent with the decrease in blood
glucose. Therefore, the failure of β-cell proliferation
in the OLETF rats should be a cause of hyper-
glycemia after a 70% pancreatectomy, rather than
an effect.
In conclusion, a 70% pancreatectomy induced
sustained non-fasting hyperglycemia in OLETF rats
which was associated with a defect in the compen-
satory proliferation of β-cells. This defect was un-
affected by restoration of normoglycemia when
phlorizin was used. Administration of nicotinamide
ameliorated this sustained hyperglycemia by increas-
ing the β-cell mass in OLETF rats. These findings
imply that the pancreatic β-cells are not able to
compensate for changes in functional demand, once
diabetogenic factors are sustained, but this defect
could be ameliorated or improved by administration
of nicotinamide, although the predisposed genetic
defect in this model rat may impair this capacity
for thev β-cell response to proliferation.
2. Are caloric restriction and exercise training
effective in preventing diabetes mellitus in the
OLETF rats ?
Caloric restriction and/or exercise training ame-
liorate glucose intolerance in NIDDM. Therefore, to
prevent the onset of NIDDM, caloric restriction and
exercise training are recommended (21). However,
there is no direct evidence for a preventive effect
on the onset of NIDDM, since such a study is not
possible in humans. Animal models, however, provide
an opportunity for such a study.
Using OLETF rats whose cumulative incidence
of diabetes mellitus is known to be 80̃90% at 24
weeks of age (4), we attempted to determine whether
caloric restriction and exercise training have pre-
ventive effects on the onset and development of
NIDDM.
Preventive effect of the interventions on
onset of diabetes
Five weeks old male OLETF rats were assigned
to three groups [exercise training, fed ad libitum
(Ex) ; sedentary, fed with caloric restriction (CR) ;
and sedentary, fed ad libitum (NT) groups]. Animals
in the Ex group were placed in individual wire mesh
cages with an exercise wheel, and were allowed to
run at their own pace. The mean length of the
running was 5,243 m / day (22). The CR group was
supplied with 70% of the amount of the food con-
sumed by the NT group. The rats of each group
were maintained until 24 weeks of age under the
conditions described above. At 24 weeks of age, an
oral glucose tolerance test (OGTT) was performed
and glucose infusion rate (GIR) was measured by
a euglycemic clamp within 2 weeks after the OGTT.
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1) The cumulative incidence
Fig.3 shows the cumulative incidence of diabetes
mellitus (left panel) and the blood glucose responses
after OGTT up to 24 weeks of age (right panel). The
cumulative incidences of diabetes mellitus in the
NT group at 10, 16 and 24 weeks of age were 30, 67
and 78%, respectively, while the cumulative inci-
dences in the Ex and the CR groups remained at
0% throughout the experimental period. The CR
group and Ex group showed significantly lower blood
glucose levels at 30, 60 and 120 min. after an oral
glucose load, as compared to the NT group. Hansen
and Bodkin reported similar findings in rhesus
monkeys (23), where the effects of sustained caloric
restriction and maintenance of normal body com-
position completely prevented the development of
NIDDM or indefinitely delayed its onset.
2) The glucose infusion rate and abdominal fat
Rats received an infusion of insulin at 60̃70
pmol/kg per min for 60 min. A variable infusion of
100 g/l glucose solution was started at time 0 and
adjusted to clamp the plasma glucose concentration
at ̃6.1 mM. Plasma samples for determination of
glucose were obtained at 2- to 5-min intervals through-
out the study. At the end of the 60 min study, the
glucose infusion rate (GIR) was calculated.
The GIRs, indexes of insulin resistance, in the
CR group (76.4±13.4 mmol/kg・min.) and the Ex
group (95.0±6.1 mmol/kg・min.) were significantly
greater than that in the NT group (36.1±5.0 mmol/
kg・min.), indicating that these interventions ame-
liorated insulin resistance. The GIRs were inversely
related to the weight of abdominal fat. Physical
activity and caloric restriction may have a protective
effect against the development of NIDDM by aiding
the maintenance of a proper lean to fat balance with
respect to body mass (22, 24). This was one of the
major mechanisms by which the trained or food
restricted rats did not become diabetic.
Kissebah has proposed that an increase in the
size of the visceral fat deposit is a precursor to
increased lipolysis and elevated free fatty acid (FFA)
flux and metabolism and to the subsequent over-
exposure of hepatic and extrahepatic tissues to FFA,
which then, in part, promotes aberrations in insulin
actions and dynamics. The resultant changes in
glucose/insulin homeostasis, lipoprotein metabo-
lism, and vascular events then lead to metabolic
morbidities such as glucose intolerance, NIDDM,
dyslipidemia, and increased risk for coronary heart
disease (25). Therefore, caloric restriction and ex-
ercise training are effective in preventing NIDDM,
probably as a result of a decreased mass of abdomi-
nal fat.
3) The structure of the pancreatic islets
The islet of sedentary OLETF rats fed ad libitum
was enlarged and had a multinodular appearance.
Clusters of endocrine cells were widely separated
from one another by bands of connective tissue.
Due totheir obesity-induced insulin insensitivity,
islets are forced to secrete more insulin in order to
overcome the loss of normal insulin sensitivity. This
may put a stress on the pancreatic β-cells, leading
to their damage and death and a concomitant
infiltration of connective tissue in the case of the
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sedentary rats fed ad libitum.
However, exercise training and caloric restriction
resulted in the maintenance of a nearly intact mor-
phological status of the pancreatic islets. Exercise
training and caloric restriction help to prevent
OLETF rats from becoming obese, resulting in
amelioration of insulin resistance, which, in turn,
prevents β-cells from overproduction of insulin
leading to the damage and death, and infiltration of
connective tissue.
Similar beneficial effects of exercise training
and caloric restriction were observed in the
micro-angio-architecture of the islets. As shown in
Fig.4, the glomerulum-like networks of the islet
capillaries from the NT rat group were sparse and
irregular, while those from the Ex and CR groups
had a dense and glomerular appearance similar to
that of the normal control, LETO rats. The adequate
vascularization of islets may not only require the
formation of a dense capillary network to ensure a
supply of oxygen to the tissue, but also include the
development of a particular micro-angio-architecture,
which guarantees the establishment of an intra-islet
portal system with core- to -mantle capillary perfusion.
Due to an insufficient supply of oxygen and nutrients,
the sparse vascularization of the islets observed in
the obese sedentary OLETF rats may result in an
acceleration of damage and death of β-cells which
are vulnerable to overwork stress. Furthermore,
alteration of the physiologic core of the islet mantle
capillary perfusion (intra-islet portal system) causes
dysfunctions of pancreatic endocrine cells, such as
the impairment of α-cell responsiveness to glucopenia
in these model rats. The α-cells of the Ex group,
which had a normal islet micro-angio-architecture
as seen in Fig.4, respond normally to glucopenia
(26). Thus, exercise training and caloric restriction
may be capable of maintaining a capillary network
as well as an intact morphology in the islets.
A separate experiment was conducted to study the
Fig.4. Micro-angio-architecture of islets. A : sedentary, fed ad libitum LETO. B : sedentary, fed ad libitum (NT) OLETF.
C : exercise training, fed ad libitum (EX) OLETF. D : sedentary, fed with caloric restriction (CR) OLETF.
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effects of caloric restriction and exercise training on
the proliferation capacity of β-cells. The sedentary
OLETF rats, fed ad libitum until 16 weeks of age,
were assigned to three groups ; exercise training, fed
ad libitum (Ex), sedentary, fed with 70% restricted
calories (CR) and sedentary, fed ad libitum (NT)
groups. They were maintained until 20 weeks of age
under the conditions described above. At 25 weeks
of age, they were sacrified and their pancreatic weight,
β-cell mass and insulin contents were measured.
Caloric restriction and exercise training normal-
ized hyperglycemia at 20 weeks of age. The insulin
contents in the pancreata of the CR group and the
Ex group rats were similarly increased, compared
to that of the NT group. The enlarged islet area
(17368±2850 mm2) in the NT group was complete-
ly or partially abolished in both the CR (8810±
1150 mm2) and the Ex groups (12947±1040 mm2).
The islet area of each group was not significantly
different from that of LETO rats (8439±558 mm2).
These results show that caloric restriction and ex-
ercise training are equally effective in preventing a
decrease in insulin content in the pancreas and an
increase in islet volume. Exercise training clearly
increases the pancreatic weight and β-cell mass while
caloric restriction does not. Therefore, exercise train-
ing appears to be more effective in augmenting
the pancreatic β-cell mass, which is decreased in
non-intervened OLETF rats.
The mechanisms through which exercise training
increases pancreatic weight and β-cell mass are
difficult to explain, but several possibilities exist.
First, exercise training alone leads to enhanced
insulin sensitivity. The GIR in the Ex OLETF group
is much higher than that in the NT OLETF group,
and nearly the same as that in the LETO group.
Such a normalized insulin sensitivity would prevent
hyperglycemia,“exhaustion”of pancreatic β-cells
and consequent cell death, perhaps resulting in
increased number of β cells. Second the increased
blood flow resulting from exercise supplies sufficient
oxygen to the β-cells for regeneration. Unfortunately,
at the present time no definitive physiological sub-
stances affecting β-cell proliferation have been
identified, although several candidates have been
proposed (27-30). Further studies will be necessary
to identify the substances responsible for β-cell
proliferation and to clarify their role in the develop-
ment of NIDDM and the amelioration of glucose
intolerance by exercise training.
As described above, both exercise training and
caloric restriction prevented the development of
diabetes mellitus in OLETF rats as a result of the
amelioration of insulin resistance, although probably
through different mechanisms.
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